Zobrazeno 1 - 10
of 24
pro vyhledávání: '"S. Salugina"'
Autor:
Konovalova Nv, I A Guseva, E. Fedorov, S. Salugina, M Yu Krylov, E Yu Samarkina, D. A. Varlamov
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 98:195-200
Autor:
M. Kaleda, I. Nikishina, E. Fedorov, S. Salugina, S. Arsenyeva, Z. Kolkhidova, A. Shapovalenko, T. Pachkoria, V. Matkava
Publikováno v:
Annals of the Rheumatic Diseases. 81:1732.2-1733
BackgroundRheumatoid factor-positive subtype of juvenile idiopathic arthritis (RF+ JIA) is a relatively rare condition (5-7% of all cases of JIA), but is associated with a poor prognosis. For these patients (pts), it is extremely important to timely
Publikováno v:
Annals of the Rheumatic Diseases. 81:1754.2-1755
BackgroundAutoinflammatory diseases (AIDs) are a heterogeneous group of rare genetically determined conditions. Biologics (B) are used, especially inhibitors of interleukin 1 (iIL-1), in the treatment of the most common monogenic AIDs (mAID) – FMF,
Autor:
Z. Kolkhidova, I. Nikishina, V. Matkava, A. Shapovalenko, S. Arsenyeva, M. Kaleda, S. Salugina, E. Fedorov, T. Pachkoria
Publikováno v:
Annals of the Rheumatic Diseases. 81:337.2-338
BackgroundThe study of the features of the course and mutual influence of the new coronavirus disease COVID-19 and various rheumatic diseases (RD) in children can still give us new lessons, warnings and fears.ObjectivesTo update the analysis in a ret
Autor:
I. Nikishina, S. Arsenyeva, V. Matkava, M. Kaleda, M. Shalygina, Z. Kolkhidova, T. Pachkoria, S. Salugina, D. Alexseev, O. Borodacheva, A. Shapovalenko
Publikováno v:
Annals of the Rheumatic Diseases. 81:1742.1-1742
BackgroundChildren and adolescents who suffered from the rare polygenic autoinflammatory disease such as multifocal non-bacterial osteomyelitis (NBO) can stay without specialized care for the long time. Currently we don’t have standardized treatmen
Publikováno v:
Annals of the Rheumatic Diseases. 81:1752.2-1752
BackgroundAutoinflammatory diseases (AIDS) are a group of rare monogenic and multifactorial diseases manifested by systemic inflammation, organ disorders, the development of complications, primarily amyloidosis, and possible death without timely targ
Publikováno v:
Annals of the Rheumatic Diseases. 81:1767.1-1767
BackgroundSchnitzler syndrome is a rare syndrome associated with recurrent whealing and monoclonal gammopathy. Since its first description in 1972 by the French dermatologist Prof. Liliane Schnitzler, around 500 cases have been described in Europe. T
Publikováno v:
Annals of the Rheumatic Diseases. 81:992.1-992
BackgroundIn recent years the use of Biologics (B) at the management of systemic lupus erythematosus including with juvenile onset (jSLE) has increased. Belimumab (BEL) became the first approved B for SLE. The use of rituximab (RTM), despite the stat
Publikováno v:
Annals of the Rheumatic Diseases. 81:1736.2-1737
BackgroundSystemic juvenile idiopathic arthritis (sJIA) is a childhood arthritis with signs of autoinflammation and high risk of macrophage activation syndrome (MAS). Immunopathogenesis of sJIA is based on excessive activation of innate immunity, whi
Autor:
M. Kaleda, I. Nikishina, S. Salugina, E. Fedorov, A. Shapovalenko, T. Pachkoria, S. Arsenyeva
Publikováno v:
Annals of the Rheumatic Diseases. 81:1731.2-1731
BackgroundPrimary Sjögren’s syndrome (pSS) is a chronic and progressive multisystem autoimmune disease which rarely onset in children and adolescents. Diagnostic delay in large part of patients are common due to the non-specific and variable sympt